# RESEARCH_AUDIT_SUMMARY.md
# Executive Quantitative Forensic Audit Summary
**System:** GEN-26 Quantitative Financial Architecture  
**Corpus / Workspace:** `c:\Users\Administrator\Desktop\New folder` (`ghalimina/Gen-26-Financial-Manager-v3`)  
**Audit Date:** 2026-09-17  
**Auditor Classification:** Senior Quantitative Research Engineer, Financial Data Engineer, Code Auditor & Statistical Validation Specialist  
**Execution Scope:** Complete Forensic State Discovery & Technical Verification  
**Policy Enforcement:** `RESEARCH_ONLY / SHADOW_ONLY / NON_PRODUCTION / NO_LIVE_TRADING / NO_ML`

---

## 1. Executive Answers to Core Audit Mandates

### A. What is actually correct?
1. **The Phase 1 Baseline (`BL3_Momentum`):**
   The pure, rule-based momentum baseline ($Mom\_20D > 0 \land Adj\_Close > SMA\_50$) is mathematically verified, point-in-time safe, and free of lookahead leakage. It delivers a robust, positive net expectancy across both development and validation periods:
   * **Development (2020–2024):** $N = 14,844$, True Net $PF = \mathbf{1.821}$ (Gross $PF = \mathbf{2.212}$), Sharpe = $\mathbf{0.697}$, Win Rate = $\mathbf{51.35\%}$.
   * **Validation (2025):** $N = 3,210$, True Net $PF = \mathbf{1.304}$ (Gross $PF = \mathbf{1.717}$), Win Rate = $\mathbf{52.49\%}$.
2. **Phase 2.75 Root-Cause Forensic Diagnoses:**
   The findings in `phase_2_75_report.md` are **100% mathematically reproducible**. The report correctly isolated:
   * The lookahead target leakage in `Breadth_AdvanceRatio`.
   * The sequential compounding distortion artifact in maximum drawdown calculations (`BUG-05`).
   * The heavy macroeconomic profit concentration in the 2022 currency devaluation ($39.9\%$ of cumulative profit).
3. **Calendar-Time Portfolio Realism (Phase 2.5):**
   When the strategy is simulated as a realistic daily Mark-to-Market portfolio with risk constraints (10% slot cap, 65% total allocation cap), the portfolio achieves **$+27.69\%$ CAGR**, daily Sharpe **$1.188$**, and maximum drawdown of **$-23.37\%$** over 2020–2025, proving economic viability under capital limits.
4. **Production Trading Core Protection:**
   All production risk gates (Cash Gate $\ge 10\%$, Allocation Cap $\le 65\%$, and 10% Position Size limits) in `core/frozen_invariants.py` and `dashboard/app.py` remain fully active, uncompromised, and protected.

---

### B. What is actually wrong?
1. **The August 19 Locked Specification Codified Forward Lookahead:**
   `research_v43/reports/phase_2_locked_specification.md` Section 1.3 defined market breadth as:
   $$\text{Pos\_1D}_i = 1 \text{ if } \text{Fwd\_Ret\_1D}_i > 0 \text{ else } 0$$
   This accessed tomorrow's return at date $t$. The original reported performance ($PF = 2.914$, Sharpe = $1.034$) was entirely manufactured by this lookahead leakage.
2. **Prior 2026 Holdout Exposure Before Locking:**
   Phase 2 walk-forward evaluations (dated 2026-08-18) evaluated data through **2026-07-19**, publishing performance breakdowns for 2026. The winning candidate (`P2_Breadth_Momentum`) was selected after observing its performance ($PF = 3.084$) in 2026. The holdout was retroactively declared "sealed" on August 19, invalidating 2026 as an untouched blind holdout.
3. **Severe Synthetic Mocking in Active Production Validators:**
   * `core/edge_verifier.py` uses `np.random.normal` (seed 42) to simulate Gaussian returns, generating fake backtest reports claiming "Statistical Edge Verified".
   * `core/statistical_validator.py` hardcodes parameter stability results using a static Python dictionary ($1.98$ to $2.138$) rather than analyzing real prices.
   * `core/weight_calibrator.py` uses nominal stock price as a fundamental quality factor (`60.0 + closes[i] / 10.0`), biasing factor models toward high-nominal-share-price equities.
   * `core/market_breadth_engine.py` compares nominal stock prices against hardcoded `ref_base = 100.0` EGP.
4. **Gross vs Net Profit Factor Discrepancy:**
   Phase 1 and Phase 2 reported Gross Profit Factors ($\sum r^+ / |\sum r^-|$) while labeling them as Net Profit Factors, artificially elevating the baseline bar by $+0.317$.
5. **Severe Zero-Volume Illiquidity in `ORAS.CA`:**
   `ORAS.CA` records **96.32% zero-volume days** and begins only in August 2021, distorting volume-weighted slippage and liquidity filters.

---

### C. What was already fixed?
1. **`BUG-01` (Corporate Action Data Quality Penalty):** Fixed in QA sweep; split adjustments are evaluated exclusively on backward-adjusted prices.
2. **`BUG-02` (Duplicate Filing Index Collision):** Fixed in QA sweep; multiple filings on the same accounting date retain the latest publication timestamp.
3. **`BUG-03` (Full-Dataset Normalization Leakage):** Fixed in Tier 6; `RobustScaler` is now fitted strictly on training folds and transformed on test folds.
4. **`BUG-04` (Market Breadth Lookahead in Research):** Fixed in Phase 2.75; `phase275_forensic_reset.py` replaced `Fwd_Ret_1D` with `Ret_1D_Trailing`.
5. **`BUG-05` (Sequential Compounding Drawdown Distortion):** Fixed in Phase 2.5; replaced artificial per-trade geometric multiplication with daily Mark-to-Market calendar portfolio simulation.

---

### D. What remains unresolved?
1. **Survivorship Bias in Research Universe:**
   The research panel comprises 27 stocks surviving and active as of 2026. The claim in Phase 2.6 Part A that survivorship was audited using 8 delisted stocks was debunked (all 8 stocks are active, listed companies). Historical win rates and profit factors retain an unavoidable upward survivorship bias.
2. **Disjoint Offset Degradation on Isolated 2025 Validation:**
   On the isolated 2025 validation year, the clean signal achieves a median Net Profit Factor of only **`1.591`**, and **75% of disjoint execution offsets fail to reach the baseline hurdle bar ($PF = 2.138$)**.
3. **Branch Divergence between Research and Production:**
   The quantitative research suite resides on branch `research/full-feature-rebuild-v43`, while the active `main` branch contains production engines running on a 2-month truncated SQLite bar database.

---

### E. Which historical reports are still trustworthy?

| Report File | Trustworthiness | Forensic Audit Verdict & Rationale |
| :--- | :---: | :--- |
| **`phase_1_report.md`** | **TRUSTWORTHY (WITH GROSS PF CAVEAT)** | Clean trailing momentum logic is verified. True Net PF is $1.821$ (reported $2.138$ is gross). |
| **`phase_2_report.md`** | **UNTRUSTWORTHY / CORRUPTED** | Corrupted by forward target lookahead in `Breadth_AdvanceRatio` and prior 2026 holdout exposure. |
| **`phase_2_locked_specification.md`**| **INVALIDATED** | Mathematically codified lookahead leakage in Section 1.3. Must be formally revoked. |
| **`phase_25_report.md`** | **TRUSTWORTHY (AS CRASH DETECTOR)** | Accurately recorded the out-of-sample collapse of the buggy candidate signal. |
| **`phase_2_75_report.md`** | **HIGHLY TRUSTWORTHY / AUTHORITATIVE** | The most rigorous, honest, and technically accurate forensic audit in the historical record. |
| **`phase_2_5_final_verdict.md`** | **PARTIALLY TRUSTWORTHY / CONTRADICTORY** | HAC and MTM portfolio calculations are correct, but reversing the verdict to `CONDITIONAL` masked that 2025 validation underperformed the baseline bar. |
| **`phase_2_6_survivorship_reconstruction.md`** | **PART A INVALIDATED / PART B TRUSTWORTHY**| Part A debunked (stocks were active, not delisted). Part B (HHI concentration 565.92) is verified. |
| **`MASTER_PROJECT_INVENTORY.md`** | **TRUSTWORTHY SUMMARY** | Transparently documents the historical bug sweep, forensic reset, and caveats. |

---

### F. Is the current Phase 2 signal valid as implemented?
**NO.**
* The original locked Phase 2 signal (`P2_Breadth_Momentum`) was fatally corrupted by forward lookahead leakage in `Breadth_AdvanceRatio`.
* The cleaned, point-in-time reconstruction (`P2_Breadth_Mom_CLEAN`) produces a Net Profit Factor of **`1.454`** in the untouched 2025 validation year.
* While it maintains positive expected net return ($+1.21\%$, HAC $p = 0.0043$), it **fails to outperform the simple Phase 1 Baseline (`BL3_Momentum`, $PF = 1.821$ Net, $2.138$ Gross) in 75% of disjoint execution windows**.
* Per the authoritative directive of `phase_2_75_report.md`, `P2_Breadth_Momentum` is **OFFICIALLY REJECTED AS AN OUTPERFORMING ALPHA CANDIDATE**.

---

### G. Is Phase 3 allowed under the existing rules?
**CONDITIONALLY ALLOWED FOR CROSS-SECTIONAL FACTOR RESEARCH ONLY.**
* Phase 3 is **NOT ALLOWED** if predicated on using `P2_Breadth_Momentum` ($PF = 2.914$) as an established alpha baseline.
* Phase 3 is **PERMITTED ONLY** under the strict governance rules established in `phase_2_75_report.md`:
  1. The sole official benchmark hurdle is reverted to **`BL3_Momentum`** ($PF = 1.821$ Net / $2.138$ Gross).
  2. Research is restricted to pure, cross-sectional factor ranking (Group A: Momentum, Group B: Value, Group C: Volatility, Group D: Liquidity).
  3. Zero post-hoc threshold optimization or parameter tuning.
  4. Machine Learning remains strictly disabled.
  5. The 2026 calendar period cannot be used as an untainted blind holdout.

---

### H. What exact evidence is needed next?
Before any advancement to an official Phase 3 factor trial:
1. **Formal Executive Revocation:** Explicit administrative approval to revoke the August 19 locked specification and establish `BL3_Momentum` as the sole baseline.
2. **Unified Clean-Room Execution:** Porting the Parquet research datasets into an isolated research directory on `main` to allow continuous regression testing.
3. **Production Synthetic Patching:** Replacing synthetic random simulations in `core/edge_verifier.py` and `core/statistical_validator.py` with real historical database queries.
4. **Post-2026 Fresh Data Reserve:** Establishing a truly unexamined out-of-sample holdout period (e.g. Q4 2026 through 2027) before any production promotion gate.

---

### I. What must remain frozen?
The following components are strictly protected and must remain **100% FROZEN**:
* **`dashboard/app.py` Production Logic**
* **Production Cash Gate** ($\ge 10\%$ cash floor)
* **Production Allocation Cap Gate** ($\le 65\%$ maximum total portfolio exposure)
* **Production Maximum Position Size Gate** ($\le 10\%$ per constituent)
* **Live Execution Firewall & Broker Gateway** (`core/live_execution_firewall.py`, `core/fix_broker_gateway.py`)
* **Live Database State & Paper Portfolios** (`data/gen26_production.db`, `data/user_real_portfolio.json`)
* **Prohibition on Machine Learning in Production** (Tier 6 remains shadow-only)

---
*Executive audit summary grounded in verified code, data, and reproducible quantitative calculations.*
